Aberrant activation of the complement system has been widely recognized as a major pathogenic factor in the development of LN, with increasing attention focused on the terminal complement component 5a (C5a) and complement component 5a receptor (C5aR1) in recent years.8 Here, C5 is linked to lobular neoplasia.